Akebia Therapeutics (AKBA)'s 30-day implied volatility (IV30) was 73.5% at the close on October 21, 2026, up from 56.0% the day before, against a 52-week range of 45.6% to 124.5%. Its 20-day historical volatility was 70.0%.
Data as of October 21, 2026.